PRLD: Prelude Therapeutics Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.07
Enterprise Value ($M) 26.94
Book Value ($M) 156.43
Book Value / Share 3.71
Price / Book 0.24
NCAV ($M) 115.60
NCAV / Share 2.74
Price / NCAV 0.33

Profitability (mra)
Return on Invested Capital (ROIC) -0.75
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.55

Liquidity (mrq)
Quick Ratio 7.04
Current Ratio 7.04

Balance Sheet (mrq) ($M)
Current Assets 156.39
Assets 197.22
Liabilities 40.79
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Vaddi Krishna
02-13 13G/A Flynn James E
2024-02-13 13G/A Ubs Asset Management Americas Inc 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 63,942 153,464 41.67
2025-02-20 65,012 162,520 40.00
2025-02-19 61,229 162,381 37.71
2025-02-18 46,584 198,289 23.49

(click for more detail)

Similar Companies
PLRX – Pliant Therapeutics, Inc. PMVP – PMV Pharmaceuticals, Inc.
PRAX – Praxis Precision Medicines, Inc. PRTA – Prothena Corporation plc
PTCT – PTC Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io